Summary: NLS Pharmaceutics Ltd will present a preclinical review at the ASCP convention exhibiting that mazindol, administered at 3 mg/kg, mitigated circadian exercise disruption in rats with narcoleptic-like indications induced by orexin-B-saporin lesions. The examine discovered … [Read more...]